Cellular Energy Status as the Main Regulator
The rate of glycolysis, particularly in skeletal muscle, is under strict control based on the cell's energy requirements. The primary indicator here is the ratio of ATP to ADP and AMP concentrations.
Even minimal consumption of intracellular energy leads to a noticeable accumulation of ATP breakdown products. The appearance of large amounts of ADP and AMP serves as the primary signal that the cell urgently requires a new supply of energy.
- Low ATP/ADP ratio (Energy deficit): Excess AMP and ADP act as potent allosteric activators, accelerating the metabolic pathway.
- High ATP/ADP ratio (Energy surplus): Accumulated ATP acts as an inhibitor, slowing down enzymatic reactions.
Key Control Points
Most reactions of glucose breakdown are fully reversible. However, there are three critical, essentially irreversible steps. Regulatory factors act precisely on these irreversible steps to determine the overall rate of ATP production.
The rate-limiting enzymes of glycolysis are:
- Hexokinase (or glucokinase in the liver)
- Phosphofructokinase-1 (PFK-1)
- Pyruvate kinase
Regulation of Phosphofructokinase-1
Phosphofructokinase-1 (PFK-1) is crucial for the entire metabolic pathway because it catalyzes the rate-limiting (slowest) committed step of the process.
Activation Mechanism: When AMP accumulates within the cell, it binds to an allosteric site on the enzyme. This interaction significantly increases PFK-1's affinity for its substrate, fructose-6-phosphate. Consequently, the rate of phosphorylation rises sharply.
Inhibition Mechanism: A high level of ATP, conversely, inhibits the process. ATP molecules bind to a distinct allosteric inhibitory site on the enzyme, inducing a conformational change. This leads to a decreased affinity for fructose-6-phosphate and an overall slowing of the reaction.
Regulation of Hexokinase and Pyruvate Kinase
If PFK-1 is inhibited by high levels of ATP, upstream intermediates—fructose-6-phosphate and glucose-6-phosphate—begin to accumulate.
Excess glucose-6-phosphate acts as a feedback inhibitor on hexokinase, halting the entry of new glucose molecules into the pathway. Important exception: Glucokinase, located in the liver and pancreatic $\beta$-cells, is not inhibited by glucose-6-phosphate, allowing these tissues to process glucose even when intracellular concentrations are high.
Pyruvate kinase catalyzes the tenth and final step of glycolysis. During the conversion of phosphoenolpyruvate (PEP) to pyruvate, substrate-level phosphorylation occurs—transferring a high-energy phosphate group to ADP to generate a new ATP molecule. Pyruvate kinase activity is also inhibited by high ATP concentrations, as well as alanine and high levels of ATP/acetyl-CoA.
Special Role of 2,3-Bisphosphoglycerate (2,3-BPG)
In most tissues, this metabolite is produced in trace amounts. However, in erythrocytes, its concentration is quite substantial via the Rapoport-Luebering shunt. Here, 2,3-BPG serves as a vital allosteric regulator of hemoglobin.
By binding to deoxygenated hemoglobin, 2,3-BPG stabilizes the T-state, lowering hemoglobin's affinity for oxygen. This promotes oxygen dissociation in peripheral tissues, facilitating oxygen delivery where it is most needed.